Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A banner about NIH terminology and transition updates was removed from the top of the page. The page continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-11-10T13:57:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer's displayed site revision changes from v3.7.2 to v3.8.0, while the study record remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T14:59:08.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about using “Super Intelligence” in place of “Artificial Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record continues to display a 403 error.
    Difference
    1%
    Check dated 2026-10-20T14:28:50.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T14:49:36.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study page now presents a 403 Forbidden error, preventing access to the study record content; previously visible details and navigation are no longer accessible.
    Difference
    18%
    Check dated 2026-09-22T21:40:48.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0. This indicates a behind-the-scenes maintenance release rather than a visible change to the content or layout.
    Difference
    0.0%
    Check dated 2026-09-15T21:47:09.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.